Physician profile

Jon Heine

Interventional Cardiology · Houston, TX

NPI 1992707012

$2,346.23

in general payments reported to CMS, 2019-2025

23 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$186.37

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $287.71 2019
Janssen Pharmaceuticals, INC $249.72 2019-2020
Amarin Pharma, INC. $208.63 2019-2020
Pfizer INC. $163.87 2019
Astrazeneca Pharmaceuticals Lp $162.29 2019-2020
Edwards Lifesciences Corporation $156.99 2024
Boston Scientific Corporation $152.06 2019-2020
Abbott Laboratories $141.03 2019-2024 Mitraclip
Boehringer Ingelheim Pharmaceuticals, INC. $133.68 2019-2020
Amgen INC. $132.17 2019
Novartis Pharmaceuticals Corporation $100.61 2019-2020
Sanofi-Aventis U.S. LLC $76.45 2019-2020
Chiesi USA, INC. $75.89 2019
E.R. Squibb & Sons, L.L.C. $61.87 2019-2020
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $48.41 2019
Show all 23 companies
CompanyGeneral paymentsYearsTop products
Arbor Pharmaceuticals, INC. $46.96 2019-2020
Biotronik INC. $38.62 2019-2020
Kowa Pharmaceuticals America, INC. $23.32 2019-2020
Medtronic Vascular, INC. $21.31 2019
Regeneron Healthcare Solutions, INC. $18.74 2019
Bardy Diagnostics, INC. $16.62 2020
Medtronic, INC. $15.06 2023 Minimed 780g
Lundbeck LLC $14.22 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Jon Heine

$2,346.23

in general payments reported 2019-2025

Years
2019-2024
Top company
Astellas Pharma US INC

https://glasscript.com/doctor/135886/jon-heine

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.